Biblio
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models. Blood Adv. 2020;4(20):5062-5077.
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation. Nat Commun. 2023;14(1):6046.